BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2300592)

  • 1. Contribution of lysophosphatidylcholine-treated nonadherent cells to mechanism of macrophage activation.
    Ngwenya BZ; Yamamoto N
    Proc Soc Exp Biol Med; 1990 Feb; 193(2):118-24. PubMed ID: 2300592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peritoneal macrophages by lysophosphatidylcholine.
    Ngwenya BZ; Yamamoto N
    Biochim Biophys Acta; 1985 Mar; 839(1):9-15. PubMed ID: 3978122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
    Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
    Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
    Yamamoto N; Homma S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.
    Ngwenya BZ; Yamamoto N
    Cancer Immunol Immunother; 1986; 21(3):174-82. PubMed ID: 2938735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of vitamin D3-binding protein in activation of mouse macrophages.
    Yamamoto N; Naraparaju VR
    J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
    Yamamoto N; Naraparaju VR
    Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.
    Homma S; Yamamoto M; Yamamoto N
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():249-57. PubMed ID: 8225394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
    Yamamoto N; Homma S; Millman I
    J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.
    Homma S; Yamamoto N
    Clin Exp Immunol; 1990 Feb; 79(2):307-13. PubMed ID: 2178824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.
    Aramaki Y; Murai M; Tsuchiya S
    Immunology; 1993 Oct; 80(2):253-8. PubMed ID: 8262553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of serum proteins in the inflammation-primed activation of macrophages.
    Yamamoto N; Willett NP; Lindsay DD
    Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
    Yamamoto N; Kumashiro R
    J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
    Yamamoto N; Homma S; Haddad JG; Kowalski MA
    Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.
    Yamamoto N; Naraparaju VR
    Immunology; 1996 Aug; 88(4):604-10. PubMed ID: 8881764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages.
    Naraparaju VR; Yamamoto N
    Immunol Lett; 1994 Dec; 43(3):143-8. PubMed ID: 7721326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mouse macrophages by in vivo and in vitro treatment with a cyanine dye, lumin.
    Yamamoto N; Homma S; Nakagawa Y; Hayami M; Imanaga H; Kurimoto M; Mitsuhashi M; Kimoto T
    J Photochem Photobiol B; 1992 May; 13(3-4):295-306. PubMed ID: 1506993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes.
    Nishi E; Kume N; Ochi H; Moriwaki H; Wakatsuki Y; Higashiyama S; Taniguchi N; Kita T
    Circ Res; 1997 May; 80(5):638-44. PubMed ID: 9130444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light.
    Yamamoto N; Homma S; Sery TW; Donoso LA; Hoober JK
    Eur J Cancer; 1991; 27(4):467-71. PubMed ID: 1827722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
    Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
    J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.